Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Due to system maintenance, login and edit functionaility is currently unavailable

Anurag Saraf, M.D.

Concepts (67)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cranial Irradiation320194340.400 Why?
Brain Neoplasms6201985900.350 Why?
Radiotherapy Planning, Computer-Assisted3202114780.220 Why?
Breast Neoplasms42018191530.180 Why?
Parotid Gland120171690.160 Why?
Taxoids220177030.150 Why?
Organs at Risk120173250.140 Why?
Doxorubicin2201722490.120 Why?
Prognosis62019289230.120 Why?
Dacarbazine120155880.120 Why?
Radiotherapy Dosage4202129910.110 Why?
Antineoplastic Agents, Alkylating120156340.110 Why?
Temporal Lobe1201916460.110 Why?
Kaplan-Meier Estimate2201769700.090 Why?
Neoplasms32022195380.090 Why?
Health Personnel1202028370.080 Why?
Neoplasm Staging22019112650.070 Why?
Retrospective Studies82022673200.070 Why?
Pandemics2202258590.070 Why?
Quality of Health Care1202043030.070 Why?
Glioblastoma2201532710.070 Why?
Delivery of Health Care1202044660.060 Why?
Proportional Hazards Models12017125250.060 Why?
Coronavirus Infections1202032230.060 Why?
Pneumonia, Viral1202033440.050 Why?
Carcinoma, Non-Small-Cell Lung1201946170.050 Why?
Aged, 80 and over42019593310.050 Why?
Survival Analysis32019107660.050 Why?
Prostatic Neoplasms12021104390.050 Why?
Time Factors22019422710.040 Why?
Chemotherapy, Adjuvant2201734860.040 Why?
Photons120216000.040 Why?
Middle Aged820192164680.040 Why?
Protons120219880.040 Why?
Aged620191622710.040 Why?
Rectum120219050.040 Why?
Neoadjuvant Therapy2201724030.040 Why?
Disease-Free Survival2201771950.040 Why?
Lung Neoplasms12019120090.040 Why?
Obesity12017117000.040 Why?
Prostate1202114320.030 Why?
New York120158560.030 Why?
Humans1220226866630.030 Why?
Adult520192114000.030 Why?
Radiation Protection120174820.030 Why?
Antineoplastic Agents12016138980.030 Why?
Brain12019242020.030 Why?
Sex Distribution1201524360.030 Why?
Age Distribution1201529630.020 Why?
Ambulatory Care1202027690.020 Why?
Lymphatic Metastasis1201630610.020 Why?
Mastectomy1201616670.020 Why?
Follow-Up Studies22019397370.020 Why?
Male620223524650.020 Why?
Healthcare Disparities1202229720.020 Why?
Female620193754590.020 Why?
Disease Progression12019132040.010 Why?
Sensitivity and Specificity12017150750.010 Why?
Case-Control Studies12019216840.010 Why?
Survival Rate12015136060.010 Why?
Body Mass Index12017123230.010 Why?
Reproducibility of Results12017193080.010 Why?
Prevalence12015147440.010 Why?
Cohort Studies12019387320.010 Why?
United States12022655790.010 Why?
Treatment Outcome12016609910.010 Why?
Risk Factors12015692780.010 Why?
Saraf's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.